HHLR ADVISORS, LTD. - Q1 2021 holdings

$10.1 Billion is the total value of HHLR ADVISORS, LTD.'s 91 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 31.6% .

 Value Shares↓ Weighting
BGNE  BEIGENE LTDsponsored adr$1,904,784,000
+34.7%
5,472,2590.0%18.82%
+67.4%
PDD SellPINDUODUO INCsponsored ads$1,368,645,000
-24.7%
10,222,922
-0.1%
13.52%
-6.4%
IQ  IQIYI INCsponsored ads$642,338,000
-4.9%
38,648,4770.0%6.35%
+18.2%
ZM SellZOOM VIDEO COMMUNICATIONS INcl a$634,858,000
-36.9%
1,975,966
-33.7%
6.27%
-21.5%
ESGR  ENSTAR GROUP LIMITED$431,245,000
+20.4%
1,747,8400.0%4.26%
+49.7%
UBER SellUBER TECHNOLOGIES INC$370,202,000
-38.0%
6,791,449
-41.9%
3.66%
-22.9%
JD SellJD.COM INCspon adr cl a$351,010,000
-70.6%
4,162,336
-69.4%
3.47%
-63.5%
CBPO  CHINA BIOLOGIC PRODS HLDGS I$350,739,000
+0.3%
2,962,0760.0%3.47%
+24.6%
BBIO BuyBRIDGEBIO PHARMA INC$330,300,000
-1.4%
5,362,014
+13.8%
3.26%
+22.5%
IMAB BuyI MABsponsored ads$320,686,000
+354.5%
6,616,170
+342.1%
3.17%
+464.9%
BEKE BuyKE HLDGS INCsponsored ads$285,589,000
-7.2%
5,012,100
+0.2%
2.82%
+15.4%
GDS  GDS HLDGS LTDsponsored ads$254,916,000
-13.4%
3,143,6230.0%2.52%
+7.6%
CRM BuySALESFORCE COM INC$240,785,000
+0.9%
1,136,476
+6.0%
2.38%
+25.4%
BILI SellBILIBILI INCspons ads rep z$213,935,000
-38.1%
1,998,271
-50.5%
2.11%
-23.1%
APLS SellAPELLIS PHARMACEUTICALS INC$195,585,000
-32.0%
4,558,029
-9.4%
1.93%
-15.5%
BEAM SellBEAM THERAPEUTICS INC$165,897,000
-31.5%
2,072,679
-30.1%
1.64%
-14.9%
DASH BuyDOORDASH INCcl a$143,758,000
+17.3%
1,096,300
+27.7%
1.42%
+45.9%
FGEN  FIBROGEN INC$137,305,000
-6.4%
3,955,7870.0%1.36%
+16.4%
MDLZ SellMONDELEZ INTL INCcl a$108,992,000
-9.3%
1,862,164
-9.4%
1.08%
+12.7%
ARGX SellARGENX SEsponsored adr$103,420,000
-25.2%
375,540
-20.1%
1.02%
-7.0%
KOD SellKODIAK SCIENCES INC$100,761,000
-40.7%
888,627
-23.2%
1.00%
-26.3%
PLTK NewPLAYTIKA HLDG CORP$89,268,0003,280,699
+100.0%
0.88%
ZTO SellZTO EXPRESS CAYMAN INCsponsored ads a$75,813,000
-22.3%
2,600,777
-22.3%
0.75%
-3.5%
BPMC SellBLUEPRINT MEDICINES CORP$73,768,000
-48.2%
758,691
-40.3%
0.73%
-35.7%
GOSS  GOSSAMER BIO INC$68,644,000
-4.3%
7,420,9740.0%0.68%
+18.7%
TIL NewINSTIL BIO INC$59,827,0002,385,457
+100.0%
0.59%
KNSA  KINIKSA PHARMACEUTICALS LTD$54,050,000
+4.8%
2,920,0230.0%0.53%
+30.2%
TUYA NewTUYA INCsponsored ads$50,208,0002,375,000
+100.0%
0.50%
AMG  AFFILIATED MANAGERS GROUP IN$49,936,000
+46.5%
335,0730.0%0.49%
+81.9%
ALGS  ALIGOS THERAPEUTICS INC$49,234,000
-17.8%
2,165,0640.0%0.49%
+2.3%
AKRO  AKERO THERAPEUTICS INC$48,060,000
+12.4%
1,656,6730.0%0.48%
+39.7%
TSM SellTAIWAN SEMICONDUCTOR MFG LTDsponsored ads$42,639,000
-2.4%
360,495
-10.0%
0.42%
+21.3%
OTIS  OTIS WORLDWIDE CORP$42,066,000
+1.3%
614,5560.0%0.42%
+26.1%
MLCO  MELCO RESORTS AND ENTMNT LTDadr$33,825,000
+7.3%
1,698,8770.0%0.33%
+33.1%
ROOT  ROOT INC$33,098,000
-19.0%
2,600,0000.0%0.33%
+0.6%
KDP SellKEURIG DR PEPPER INC$33,000,000
-16.3%
960,154
-22.1%
0.33%
+3.8%
HTHT BuyHUAZHU GROUP LTDsponsored ads$31,782,000
+26.7%
578,902
+3.9%
0.31%
+57.8%
FMTX  FORMA THERAPEUTICS HLDGS INC$30,822,000
-19.7%
1,100,0000.0%0.30%0.0%
BABA NewALIBABA GROUP HLDG LTDsponsored ads$30,767,000135,700
+100.0%
0.30%
ALLO  ALLOGENE THERAPEUTICS INC$28,240,000
+39.9%
800,0000.0%0.28%
+73.3%
PRLD SellPRELUDE THERAPEUTICS INC$27,146,000
-49.4%
626,502
-16.5%
0.27%
-37.2%
CALT SellCALLIDITAS THERAPEUTICS ABsponsered ads$26,103,000
-26.7%
944,716
-9.8%
0.26%
-8.8%
AAPL SellAPPLE INC$24,430,000
-38.6%
200,000
-33.3%
0.24%
-23.7%
XPEV NewXPENG INCads$24,045,000658,595
+100.0%
0.24%
BEDU  BRIGHT SCHOLAR ED HLDGS LTDsponsored ads$23,118,000
+0.7%
3,985,7970.0%0.23%
+24.6%
OLMA  OLEMA PHARMACEUTICALS INC$20,585,000
-31.0%
620,3970.0%0.20%
-14.3%
AXSM  AXSOME THERAPEUTICS INC$20,383,000
-30.5%
360,0000.0%0.20%
-13.7%
MOGU  MOGU INCspon ads$20,267,000
-10.6%
10,446,9700.0%0.20%
+11.1%
KRON  KRONOS BIO INC$19,272,000
-2.0%
658,4360.0%0.19%
+21.8%
LEGN  LEGEND BIOTECH CORPsponsored ads$18,863,000
+3.1%
650,0000.0%0.19%
+27.4%
KURA  KURA ONCOLOGY INC$18,376,000
-13.4%
650,0000.0%0.18%
+7.7%
ACMR BuyACM RESEARCH INC$18,063,000
+3.8%
223,585
+4.4%
0.18%
+29.7%
RGNX  REGENXBIO INC$15,554,000
-24.8%
456,0000.0%0.15%
-6.1%
DYN BuyDYNE THERAPEUTICS INC$15,530,000
+23.3%
1,000,000
+66.7%
0.15%
+53.0%
SNOW SellSNOWFLAKE INCcl a$14,445,000
-84.7%
63,000
-81.2%
0.14%
-81.0%
VIPS NewVIPSHOP HOLDINGS LIMITEDsponsored ads a$14,034,000470,000
+100.0%
0.14%
SOHU  SOHU COM LTDsponsored ads$12,608,000
-1.4%
802,0340.0%0.12%
+22.5%
ADCT  ADC THERAPEUTICS SA$12,205,000
-23.7%
500,0000.0%0.12%
-4.7%
IMCR NewIMMUNOCORE HLDGS PLCads$11,902,000279,580
+100.0%
0.12%
NKTX SellNKARTA INC$11,828,000
-65.4%
359,528
-35.3%
0.12%
-57.0%
IGMS  IGM BIOSCIENCES INC$11,610,000
-13.1%
151,3900.0%0.12%
+8.5%
GRUB  GRUBHUB INC$10,163,000
-19.2%
169,3860.0%0.10%0.0%
MREO  MEREO BIOPHARMA GROUP PLCads$10,030,000
-5.9%
2,976,1210.0%0.10%
+16.5%
HOOK SellHOOKIPA PHARMA INC$9,893,000
-5.4%
735,570
-22.0%
0.10%
+18.1%
PYPL NewPAYPAL HLDGS INC$9,714,00040,000
+100.0%
0.10%
RNA  AVIDITY BIOSCIENCES INC$9,269,000
-14.5%
425,0000.0%0.09%
+7.0%
COGT  UNUM THERAPEUTICS INC$8,780,000
-21.8%
1,000,0000.0%0.09%
-2.2%
GMAB SellGENMAB A/Ssponsored ads$8,717,000
-84.7%
265,529
-81.1%
0.09%
-81.1%
DSGN NewDESIGN THERAPEUTICS INC$8,402,000280,991
+100.0%
0.08%
MNSO SellMINISO GROUP HLDG LTDsponsored ads$7,141,000
-31.0%
297,288
-24.1%
0.07%
-13.4%
FDMT Sell4D MOLECULAR THERAPEUTICS IN$6,832,000
-26.7%
157,500
-30.0%
0.07%
-8.1%
LPTX SellLEAP THERAPEUTICS INC$6,794,000
-18.8%
3,575,745
-3.8%
0.07%
+1.5%
NXTC SellNEXTCURE INC$5,645,000
-18.9%
563,907
-11.7%
0.06%
+1.8%
CDAK  CODIAK BIOSCIENCES INC$5,530,000
-53.3%
366,7210.0%0.06%
-41.5%
CJJD  CHINA JO-JO DRUGSTORES INC$5,421,000
+10.9%
4,840,0000.0%0.05%
+38.5%
CYTK  CYTOKINETICS INC$5,367,000
+12.0%
230,7180.0%0.05%
+39.5%
MAACU  MONTES ARCHIMEDES ACQUISITIOunit 09/30/2025$5,100,000
-2.9%
500,0000.0%0.05%
+19.0%
NIO NewNIO INCspon ads$4,958,000127,200
+100.0%
0.05%
CVET  COVETRUS INC$4,649,000
+4.3%
155,1240.0%0.05%
+31.4%
NTES NewNETEASE INCsponsored ads$4,492,00043,500
+100.0%
0.04%
SFUN BuyFANG HLDGS LTDadr new$4,099,000
+919.7%
327,920
+993.1%
0.04%
+1266.7%
RXDX NewPROMETHEUS BIOSCIENCES INC$3,652,000200,000
+100.0%
0.04%
YSG SellYATSEN HLDG LTDads$3,097,000
-90.9%
250,764
-87.5%
0.03%
-88.6%
UXIN  UXIN LTDads$2,688,000
+34.1%
2,297,3180.0%0.03%
+68.8%
DGNRU  DRAGONEER GROWTH OPPORTUN COunit 08/18/2027$2,080,000
-25.7%
200,0000.0%0.02%
-4.5%
RCUS SellARCUS BIOSCIENCES INC$1,404,000
-91.3%
50,000
-92.0%
0.01%
-89.1%
EDU NewNEW ORIENTAL ED & TECHNOLOGYspon adr$1,103,00078,771
+100.0%
0.01%
MRUS SellMERUS N V$972,000
-90.8%
46,532
-92.2%
0.01%
-88.1%
TCRR SellTCR2 THERAPEUTICS INC$874,000
-91.2%
39,577
-87.7%
0.01%
-88.6%
CIH  CHINA INDEX HLDGS LTDspnsrd ads a$654,000
+10.7%
300,0000.0%0.01%
+20.0%
LEAPU  RIBBIT LEAP LTDunit 99/99/9999$550,000
-26.6%
50,0000.0%0.01%
-16.7%
CVAC ExitCUREVAC N V$0-51,199
-100.0%
-0.03%
CBMG ExitCELLULAR BIOMEDICINE GROUP I$0-235,214
-100.0%
-0.03%
ATNX ExitATHENEX INC$0-431,440
-100.0%
-0.04%
AVIR ExitATEA PHARMACEUTICALS INC$0-125,000
-100.0%
-0.04%
FUTU ExitFUTU HLDGS LTDspon ads cl a$0-150,000
-100.0%
-0.06%
GTHX ExitG1 THERAPEUTICS INC$0-474,716
-100.0%
-0.07%
TXG Exit10X GENOMICS INC$0-75,000
-100.0%
-0.08%
BLI ExitBERKELEY LTS INC$0-200,000
-100.0%
-0.14%
EIDX ExitEIDOS THERAPEUTICS INC$0-178,600
-100.0%
-0.19%
ABCL ExitABCELLERA BIOLOGICS INC$0-600,000
-100.0%
-0.19%
Z ExitZILLOW GROUP INCcl c cap stk$0-302,336
-100.0%
-0.31%
MELI ExitMERCADOLIBRE INC$0-27,525
-100.0%
-0.37%
YQ Exit17 ED & TECHNOLOGY GROUP INCads$0-4,643,391
-100.0%
-0.47%
SE ExitSEA LTDsponsord ads$0-337,622
-100.0%
-0.53%
VIE ExitVIELA BIO INC$0-2,382,414
-100.0%
-0.68%
ALGN ExitALIGN TECHNOLOGY INC$0-182,283
-100.0%
-0.77%
TAL ExitTAL EDUCATION GROUPsponsored ads$0-4,055,722
-100.0%
-2.31%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BEIGENE LTD20Q3 202326.0%
JD.COM INC20Q3 202313.1%
IQIYI INC20Q3 202312.3%
MONDELEZ INTL INC20Q3 20235.9%
KINIKSA PHARMACEUTICALS LTD20Q3 20231.6%
SOHU COM LTD20Q3 20230.6%
PINDUODUO INC19Q3 202316.1%
GOSSAMER BIO INC19Q3 20232.3%
BRIDGEBIO PHARMA INC18Q3 20233.4%
MELCO RESORTS AND ENTMT LTD18Q1 20232.8%

View HHLR ADVISORS, LTD.'s complete holdings history.

Latest significant ownerships (13-D/G)
HHLR ADVISORS, LTD. Q1 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
I-MabJune 30, 202315,891,2118.3%
BeiGene, Ltd.February 14, 2023147,043,05810.9%
Gossamer Bio, Inc.February 14, 20234,974,0415.3%
On Holding AGFebruary 14, 20235,468,5041.9%
Root, Inc.February 14, 2023138,9771.5%
Yatsen Holding LtdFebruary 14, 2023300,560,60219.1%
iQIYI, Inc.July 11, 2022149,075,9125.0%
Apellis Pharmaceuticals, Inc.February 14, 2022? ?
Beam Therapeutics Inc.February 14, 2022? ?
Futu Holdings LtdFebruary 14, 20222-

View HHLR ADVISORS, LTD.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
42024-02-01
13F-HR2023-11-14

View HHLR ADVISORS, LTD.'s complete filings history.

Compare quarters

Export HHLR ADVISORS, LTD.'s holdings